Growth hormone deficiency
Pfizer Canada ULC
NOC Status at Filing:
Manufacturer Requested Reimbursement Criteria1:
Long-term treatment of pediatric patients who have growth hormone deficiency.
Long-term treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone.
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.